You just read:

Regulus Expands its Biomarkers Platform and Establishes Regulus microMarkers™, a New R&D Division Focused on Identifying microRNAs as Biomarkers of Disease

News provided by

Regulus Therapeutics Inc.

Jan 13, 2014, 08:00 EST